Novel Regulatory Effect of Angiotensin II Type 1 Receptor-Interacting Molecule on Vascular Smooth Muscle Cells
Colocalization
DOI:
10.1161/hypertensionaha.107.096115
Publication Date:
2007-09-18T01:09:46Z
AUTHORS (13)
ABSTRACT
We have recently cloned a novel molecule that interacts with the angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP). In this study, we tested hypothesis ATRAP modulates II-induced responses in vascular smooth muscle cells. The results of immunoprecipitation and bioluminescence resonance energy transfer assay demonstrated direct interaction between AT1R at baseline showed enhanced these proteins >2-fold. immunofluorescence analysis also >65% constitutively colocalized an endosome marker. Although only 36% baseline, colocalization molecules made 92% colocalize on quantitative fluorescence analysis. Overexpression by adenoviral decreased cell surface number from 4.33 to 2.13 fmol/10 6 cells 3.04 1.26 even after removal II. suppressed II-mediated increases c-fos gene transcription transforming growth factor-β production. Furthermore, suppression was accompanied inhibition activation 5-bromodeoxyuridine incorporation. Finally, knockdown small-interference RNA activated expression, which effectively inhibited valsartan, AT1R-specific antagonist. These indicate promotes internalization attenuates c-fos-transforming pathway proliferative response cells, suggesting strategy inhibit fibrosis remodeling through specific blockade signaling.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....